1.6 C
New York
Tuesday, March 4, 2025
- Advertisement -spot_img

TAG

aducanumab fda approval

Buying Biogen Inc. Check here for the analysis, revealed market

Biogen Inc. (NASDAQ: BIIB) stock’s Relative Strength Index is 63.15, with weekly volatility at 3.20% and ATR of 7.35%. The BIIB stock's 52-week price...

Latest news

- Advertisement -spot_img